No Data
No Data
Willow Biosciences Cancels Non-Brokered Offering to Pursue "Less Dilutive" Financing
Willow Biosciences Brief: Announcing Non-Brokered Private Placement Offer To Raise Up to $2 Million
Willow Biosciences Inc: INTERIM MDA EN
Willow Biosciences Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT
Willow Biosciences Announces Commercial License and Royalty Agreement With Kalsec